Investing.com -- Wellgistics Health Inc (NASDAQ:WGRX) stock surged 9.2% on Monday after the health information technology company announced the commercial launch of diabetes prescription drug ...

Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are ...

Medicare’s 2026 drug price negotiations under the Inflation Reduction Act aim to lower the cost of expensive medications, ...

A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...

A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...

Discover how new U.S. Medicare drug price cuts impact major pharma stocks like Novo Nordisk and why sector resilience ...

CMS announces billions in savings for Medicare when first and second rounds of negotiations go into effect in 2026 and 2027, ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found.

Medical malpractice: Suit alleges that health care providers negligently prescribed Jardiance medication, resulting in severe complications including diabetic ketoacidosis and multiple amputations, ...